Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/science.1234998 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Proposed framework for the integration of refractive error services into the eye health ecosystem in Kenya via social enterprise.
Sci Rep
January 2025
College of Health Sciences, Department of Optometry, University of KwaZulu-Natal, Durban, South Africa.
The global burden of uncorrected refractive error demands for adoption of different approaches inclined towards scaling effective refractive error coverage. While innovative approaches such as utilization of telemedicine is being adopted by social enterprises in different parts of the world to scale refractive error service delivery, commercial entrepreneurship still dominates the optical industry in Kenya with minimal focus on accessibility and affordability. However, to achieve effective refractive error coverage across the economic pyramid, integration of enterprises inclined towards fulfilling a social mission through innovative approaches such as telemedicine is desirable.
View Article and Find Full Text PDFWorking during the second degree: A survey of dentally qualified medical students pursuing a career in OMFS.
Br J Oral Maxillofac Surg
December 2024
Department of Oral & Maxillofacial Surgery, King's College Hospital, London, SE5 9RS, United Kingdom. Electronic address:
Attaining degrees in both medicine and dentistry to forge a career in Oral and Maxillofacial Surgery (OMFS) comes at a considerable financial cost. To fund a second degree most must work alongside their full-time studies. This study aims to assess the current working roles and patterns of those qualified in dentistry, studying medicine to pursue a career in OMFS.
View Article and Find Full Text PDFHow to facilitate the wider use of pharmacogenetic tests?
Therapie
December 2024
Centre de biologie et de recherche en santé, pharmacologie, toxicologie et pharmacovigilance, CHU de Limoges, 87042 Limoges, France.
4P medicine (personalized, preventive, predictive, and participatory) is experiencing a remarkable rise, and pharmacogenetics is an essential part of it. However, several obstacles are hindering its deployment. This round table brought together a group of experts to take stock of the situation, reflecting on ways to facilitate the prescription of these tests and the dissemination of the results on a national scale.
View Article and Find Full Text PDFChildhood hand, foot and mouth disease sequelae cohort study in Henan, China: cohort profile.
BMJ Open
January 2025
College of Public Health, Zhengzhou University, Zhengzhou, Henan, China
Purpose: The childhood hand, foot and mouth disease (HFMD) sequelae cohort study (HNHFMDCS) is an ambispective cohort study of patients with HFMD based in Henan Province, China, consisting of patients treated in a key hospital for the diagnosis and treatment of HFMD in Henan Province. The study aims to investigate the long-term sequelae of HFMD survivors and to provide a comprehensive understanding of the potential harm caused by this infectious disease.
Participants: In the retrospective phase of the cohort study, children diagnosed with HFMD from January 2014 to January 2023 were included, and clinical and demographic information about the patients was collected through a self-developed questionnaire.
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration.
Int J Pharm
January 2025
Department of Mechanical Engineering, K. N. Toosi University of Technology, Tehran, Iran; Department of Electrical and Computer Engineering, University of Waterloo, Waterloo, Canada; Centre for Biotechnology and Bioengineering (CBB), University of Waterloo, Waterloo, Canada; Department of Integrative Oncology, BC Cancer Research Institute, Vancouver, Canada; Centre for Sustainable Business, International Business University, Toronto, Canada. Electronic address:
The blood-brain barrier (BBB) plays a vital role in protecting the central nervous system (CNS) by preventing the entry of harmful pathogens from the bloodstream. However, this barrier also presents a significant obstacle when it comes to delivering drugs for the treatment of neurodegenerative diseases and brain cancer. Recent breakthroughs in nanotechnology have paved the way for the creation of a wide range of nanoparticles (NPs) that can serve as carriers for diagnosis and therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!